Found: 17
Select item for more details and to access through your institution.
Brain FDG-PET: clinical use in dementing neurodegenerative conditions.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1467, doi. 10.1007/s00259-018-4027-y
- By:
- Publication type:
- Article
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1470, doi. 10.1007/s00259-018-4024-1
- By:
- Publication type:
- Article
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1487, doi. 10.1007/s00259-018-4032-1
- By:
- Publication type:
- Article
Clinical utility of FDG-PET for the clinical diagnosis in MCI.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1497, doi. 10.1007/s00259-018-4039-7
- By:
- Publication type:
- Article
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1509, doi. 10.1007/s00259-018-4035-y
- By:
- Publication type:
- Article
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1526, doi. 10.1007/s00259-018-4034-z
- By:
- Publication type:
- Article
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1534, doi. 10.1007/s00259-018-4031-2
- By:
- Publication type:
- Article
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1546, doi. 10.1007/s00259-018-4033-0
- By:
- Publication type:
- Article
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1557, doi. 10.1007/s00259-018-4030-3
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1567, doi. 10.1007/s00259-018-4017-0
- By:
- Publication type:
- Article
Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1573, doi. 10.1007/s00259-018-4009-0
- By:
- Publication type:
- Article
The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1585, doi. 10.1007/s00259-018-4019-y
- By:
- Publication type:
- Article
Quantitative evaluation of tau PET tracers <sup>18</sup>F-THK5351 and <sup>18</sup>F-AV-1451 in Alzheimer’s disease with standardized uptake value peak-alignment (SUVP) normalization.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1596, doi. 10.1007/s00259-018-4040-1
- By:
- Publication type:
- Article
Dual tracer tau PET imaging reveals different molecular targets for <sup>11</sup>C-THK5351 and <sup>11</sup>C-PBB3 in the Alzheimer brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1605, doi. 10.1007/s00259-018-4012-5
- By:
- Publication type:
- Article
Noradrenaline transporter availability on [<sup>11</sup>C]MRB PET predicts weight loss success in highly obese adults.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1618, doi. 10.1007/s00259-018-4002-7
- By:
- Publication type:
- Article
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1626, doi. 10.1007/s00259-018-3992-5
- By:
- Publication type:
- Article
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with <sup>213</sup>Bi-substance P analogue.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1636, doi. 10.1007/s00259-018-4015-2
- By:
- Publication type:
- Article